Symptomatic arterial hypertension associated with primary hyperaldosteronism
https://doi.org/10.18705/1607-419X-2017-23-3-224-230
Abstract
Objective. Primary hyperaldosteronism (PGA) (Conn’s syndrome) is a relatively rare phenomenon in therapeutic practice, occurring in 4,7–9%. In resistant hypertension (HTN) the rate of PGA achieves 10–20%. Often it results from the aldosterone-producing adrenal tumors and manifests by symptomatic HTN, neuromuscular, and renal symptoms. We present the cases of successful verification and surgical treatment of PGA. HTN patients and patients with rhabdomyolysis symptoms (increased creatine phosphokinase or lactate dehydrogenase) require further examination to exclude PGA.
About the Authors
A. N. Kalyagin
Irkutsk State Medical University, Irkutsk
Russian Federation
Russian Federation
MD, PhD, DSc, Professor, Head, Department of Internal Medicine Propaedeutics
PO Box 62, Irkutsk, 664046
Phone: +7(3952)24–36–61
V. A. Beloborodov
Irkutsk State Medical University, Irkutsk
Russian Federation
MD, PhD, DSc, Professor, Head, Department of General Surgery
Russian Federation
MD, PhD, DSc, Professor, Head, Department of General Surgery
T. M. Maksikova
Irkutsk State Medical University, Irkutsk
Russian Federation
MD, PhD, Assistant, Department of Internal Medicine Propaedeutics
Russian Federation
MD, PhD, Assistant, Department of Internal Medicine Propaedeutics
References
1. Бельцевич Д.Г. Первичный гиперальдостеронизм. Клинические рекомендации. Эндокринная хирургия. 2008;2:6– 20. [Beltsevich DG. Primary hyperaldosteronism. Clinical recommendations. Endokrinnaya Khirurgia = Endocrine Surgery. 2008;2:6–20. In Russian].
2. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. doi:10.1210/jc.2015–4061
3. Дедов И. И., Мельниченко Г. А. Эндокринология. Национальное руководство. М.: ГЭОТАР-Медиа, 2013. 741 с. [Dedov II, Melnichenko GA. Endocrinology. National leadership. Moscow: GEOTAR-Media, 2013. 741 p. In Russian].
4. Левитская З.И., Вабищевич А.А., Перистая Е.В. Первичный идиопатический гиперальдостеронизм в клинической перспективе. Лечащий врач. 2006;2:18–20. [Levitskaya ZI, Vabishchevich AA, Peristaya EV. Primary idiopathic hyperaldosteronism in clinical perspective. Lechaschij Vrach = Physician. 2006;2:18–20. In Russian].
5. Miyaji Y, Kawabata Y, Joki H, Seki S, Mori K, Kamide T et al. Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. BMC Neurol. 2016;16:177. doi:10.1186/s12883–016–0701–5
6. Galati SJ, Cheesman KC, Springer-Miller R, Hopkins SM, Krakoff L, Bagiella E et al. Prevelence of primary aldosteronism in an urban hypertensive population. Endocr Pract. 2016;22(11):1296– 1302. doi:10.4158/E161332.OR
7. Li N, Yao X, Zhou L, Abulikem S, Zhang D, Chang G et al. Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China. J Hypertens. 2016;34(Suppl 1): ISH 2016 Abstract Book: e240. doi:10.1097/01.hjh.0000500536.98490.39
8. Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811–1820. doi:10.1016/j.jacc.2017.01.052
9. Woolsey S, Brown B, Ralls B, Friedrichs M, Stults B. Diagnosing hypertension in primary care clinics according to current guidelines. J Am Board Fam Med. 2017;30(2):170–177. doi:10.3122/jabfm.2017.02.160111
10. Maiolino G, Calò LA, Rossi GP. The time has come for systematic screening for primary aldosteronism in all hypertensives. J Am Coll Cardiol. 2017;69(14):1821–1823. doi:10.1016/j. jacc.2017.02.041
11. Аснер Т.В., Калягин А. Н., Зимина И. А. Рабдомиолиз: современное состояние проблемы. Современные проблемы ревматологии. 2012;4:101–106. [Asner TV, Kalyagin AN, Zimina IA. Rhabdomyolysis: the current state of the problem. Sovremenniye Problemy Reumatologii = Modern Problems of Rheumatology. 2012;4:101–106. In Russian].
12. Lee JH, Kim E, Chon S. Hypokalemia-induced rhabdomyolysis by primary aldosteronism coexistent with sporadic inclusion body myositis. Ann Rehabil Med. 2015;39 (5):826–32. doi:10.5535/arm.2015.39.5.826
13. Киселева Е. Р., Нашатырева М. С., Федотова В. Н., Фадеева Т.М., Черных С.Ю., Куимов П.А. и др. Первичный гипер-альдостеронизм в терапевтической практике. Сибирский медицинский журнал (Иркутск). 2016;144(5):41–44. [KiselevaER, Nashatyreva MS, Fedotova VN, Fadeeva TM, Chernykh SYu, Kuimov PA et al. Primary hyperaldosteronism in therapeutic practice. Sibirskij Meditsinskij Zurnal (Irkutsk). 2016;144(5): 41–44. In Russian].
14. Молашенко Н.В., Трошина Е. А. Первичный идиопатический гиперальдостеронизм в клинической практике. Ожирение и метаболизм. 2012;4:3–9. [Molashenko NV, Troshina EA. Primary idiopathic hyperaldosteronism in clinical practice. Ozhireniye i Metabolizm = Obesity and Metabolism. 2012;4:3–9. In Russian].
15. Пинский С.Б., Белобородов В.А., Дворниченко В.В. Множественные эндокринные неоплазии. Новосибирск: Наука, 2012. 164 с. [Pinsky SB, Beloborodov VA, Dvornichenko VV. Multiple endocrine neoplasias. Novosibirsk: Science, 2012. 164 p. In Russian].
16. Пинский С.Б., Белобородов В.А., Дворниченко В.В., Батороев Ю.К. Нейроэндокринные опухоли. Новосибирск: Наука, 2016. 356 с. [Pinsky SB, Beloborodov VA, Dvornichenko VV, Batoroyev YuK. Neuroendocrine tumors. Novosibirsk: Science, 2016. 356 p. In Russian].
17. Пинский С.Б., Колмаков С.А., Килин А.Г., Федорова О. А. Случай атипичного варианта синдрома МЭН. Сибирский медицинский журнал (Иркутск). 2006;62(4):81–83. [Pinsky SB, Kolmakov SA, Kilin AG, Fiodorova OA. The case of atypical variant of syndrome MEN. Sibirskij Meditsinskij Zurnal (Irkutsk) = Siberian Medical Journal (Irkutsk). 2006;62(4):81–83. In Russian].
18. Piaditis G, Markou A, Papanastasiou L, Androulakis II, Kaltsas G. Progressin aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2015;172(5): R191–203. doi:10.1530/EJE 14–0537
19. Carey RM. Diagnosing and managing primary aldosteronism in hypertensive patients: a case-based approach. Curr Cardiol Rep. 2016;18(10):97. doi:10.1007/s11886–016–0774–1
20. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Endocrine society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266–3281. doi:10.1210/jc.2008–0104
21. Dutta RK, Söderkvist P, Gimm O. Genetics of primary hyperaldosteronism. Endocr Relat Cancer. 2016;23(10): R437–54. doi:10.1530/ERC 16–0055
22. Белобородов В. А., Высоцкий В. Ф. Эффективность дифференциальной диагностики новообразования надпочечников. Сибирский медицинский журнал (Иркутск). 2011;100 (1):59–61. [Beloborodov VA, Vysotsky VF. The effectiveness of the differential diagnosis of tumors of the adrenal glands. Sibirskij Meditsinskij Zurnal (Irkutsk) = Siberian Medical Journal (Irkutsk). 2011;100(1):59–61. In Russian].
23. Белобородов В.А., Высоцкий В.Ф., Щербатых А.В. Отдаленные результаты хирургического лечения больных при новообразованиях надпочечников. Бюллетень Восточно- Сибирского научного центра Сибирского отделения Российской академии медицинских наук. 2011;3–2:9–11. [Beloborodov VA, Vysotsky VF, Shcherbatyh AV. Long-term results of surgical treatment of patients with tumors of the adrenal glands. Bjulleten’ Vostochno-Sibirskogo Nauchnogo Zentra Sibirskogo Otdelenija Rossijskoj Akademii Medicinskih Nauk = Bulletin of the EasternSiberian Scientific Centre of the Siberian Branch of the Russian Academy of Science. 2011;3–2:9–11. In Russian].
24. Высоцкий В.Ф., Белобородов В.А. Результаты хирургического лечения больных с новообразованиями надпочечников. Сибирский медицинский журнал (Иркутск). 2011;100: (1):175–177. [Vysotsky VF, Beloborodov VA. Results of surgical treatment of patients with tumors of the adrenal glands. Sibirskij Meditsinskij Zurnal (Irkutsk) = Siberian Medical Journal (Irkutsk). 2011;100(1):175–177. In Russian].
Review
For citations:
Kalyagin A.N., Beloborodov V.A., Maksikova T.M. Symptomatic arterial hypertension associated with primary hyperaldosteronism. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2017;23(3):224-230. (In Russ.) https://doi.org/10.18705/1607-419X-2017-23-3-224-230
Views:
4458
Email this article 